Cord banking is unlikely to pay off for most families, and the costs often outweigh the benefits

Cord blood banking — storing your newborn's umbilical cord blood for potential future medical use — costs between $1,400 and $2,300 upfront, then $100 to $300 per year in storage fees. The pitch is that those cells might treat leukemia, lymphoma, or other blood disorders decades from now. The reality: your child has roughly a 1 in 400 to 1 in 200 chance of ever using their own cord blood, and that estimate comes from the American Academy of Pediatrics, not a marketing department. Public cord banks (free to donate, free to store) exist in most states and serve the same medical purpose without the cost. Private banks make money by banking your cells; they have financial incentive to suggest the odds are higher than they are.

The decision comes down to whether you are paying thousands for insurance against a low-probability event, with no may provide the cells will remain viable if that event occurs. For most families without a family history of blood disorders, the math does not support the expense.

Key Takeaways

  • Private cord banking costs $1,400 to $2,300 upfront plus $100 to $300 yearly, while public donation is free and serves the same medical purpose.
  • The chance your child will ever use their own cord blood is roughly 1 in 200 to 1 in 400, according to the American Academy of Pediatrics.
  • Cord blood stored for decades may lose viability, and thawing success rates are not may provide, so future use is not certain even if a disease develops.
  • If a genetic disease runs in your family, your child's own cord blood cannot treat it, making public banking or a family member's donation more useful.
  • The FDA does not regulate private cord banks the way it regulates blood banks, so storage quality and long-term survival rates vary widely.

How private cord banking works and what it costs

When you choose private cord banking, a company collects blood from the umbilical cord after birth, processes it, and stores it in liquid nitrogen at their facility. You pay an initial collection and processing fee — typically $1,400 to $2,300 — and then annual storage fees of $100 to $300. The company keeps your child's cells on file indefinitely, or until you stop paying or the company closes.

The bank sends you a kit before your due date. After delivery, the hospital or midwife collects the cord blood using the kit, and you ship it to the bank. Processing takes a few weeks. The company then stores the sample and sends you documentation. If your child develops a may have access to blood disorder later in life, you contact the bank, pay a retrieval fee (usually $200 to $500), and the cells are thawed and sent to a hospital for transplant.

Private banks are for-profit businesses. They market directly to parents and make their money by signing up as many families as possible. This creates a financial incentive to present the odds of future use as favorably as possible, which is why marketing materials often emphasize potential future treatments rather than current medical reality.

Public cord banking: the free alternative with the same medical value

Public cord banks operate like blood banks. You donate your child's cord blood at no cost. The bank processes and stores it, and any patient in the country who needs a match can receive it. You have no claim to the cells after donation — they belong to the public bank and the medical system.

Public banks exist in most U.S. states and are regulated by the FDA. They follow the same medical standards as private banks and have been used successfully in thousands of transplants. If your child develops a blood disorder, they can receive cord blood from a public bank donor (which may or may not be their own stored cells, depending on availability and match).

The trade-off is clear: public banking costs you nothing but gives up your child's exclusive access to their own cells. Private banking preserves that access but costs thousands. For most families, the odds do not justify the expense, and the medical outcome — access to cord blood transplants if needed — is the same either way.

The actual odds your child will use their own cord blood

The American Academy of Pediatrics estimates the chance a child will use their own stored cord blood by age 20 at roughly 1 in 400. By age 70, the estimate rises to 1 in 200. These numbers assume current medical knowledge and transplant practices; they do not account for future breakthroughs that might expand use.

Those odds mean that if 200 families pay for private banking, roughly one child will ever use their stored cells. The other 199 families will have paid thousands in upfront and annual fees for cells that are never used. Over 20 years of storage at $150 per year, a family pays roughly $4,400 total ($1,900 upfront plus $2,500 in storage). The expected value — the average payout if you repeated this decision across many families — is roughly $22 per family.

The odds are higher if your child has a sibling with a diagnosed blood disorder — in that case, your newborn's cord blood might treat the older child. But even then, public banking through a directed donation program (where you donate specifically for a family member) is often free or low-cost and serves the same purpose.

Why your child's own cord blood may not work for genetic diseases

Many families consider cord banking because a genetic blood disorder runs in the family. This reasoning has a critical flaw: if your child inherited the genetic mutation, their own cord blood carries the same mutation and cannot treat the disease. Cord blood transplants work for acquired disorders (like leukemia) but not for inherited genetic conditions.

If your family has a history of sickle cell disease, thalassemia, or other inherited blood disorders, storing your child's own cord blood offers no protection. A sibling's cord blood or an unrelated donor match from a public bank would be useful, but your child's own cells would not. This is a major reason the American Academy of Pediatrics does not recommend routine private cord banking for most families.

The confusion arises because cord blood transplants do treat blood disorders — just not the inherited kind. If your child develops leukemia at age 30, cord blood can help. If your child inherited a genetic mutation at conception, cord blood from that same child cannot fix it.

Storage viability and the uncertainty of thawing decades later

Cord blood stored in liquid nitrogen can theoretically last indefinitely, but in practice, viability degrades over time. Cells that have been frozen for 20 or 30 years may not thaw successfully, or may have reduced function after thawing. No private bank has data on cells stored for 50+ years because cord banking as a commercial service has only existed since the 1990s.

When cells are thawed for transplant, success is not may provide. Thawing can damage cells, and the transplant itself may fail. The longer cells have been stored, the higher the risk of degradation. A child born today who needs a transplant at age 40 or 50 is betting that their 40- or 50-year-old cells will still be viable — a bet with no historical data to back it up.

Private banks do not publish detailed long-term viability data, partly because they do not have it yet. Some banks report thawing success rates of 80 to 90 percent for cells stored 10 to 15 years, but rates for longer storage periods are unknown. This uncertainty is another reason to be cautious about the investment.

FDA regulation and quality differences between private banks

Private cord banks are not regulated by the FDA the way blood banks are. The FDA oversees some aspects of cord blood banking, but oversight is lighter than for traditional blood banking. This means storage conditions, processing methods, and quality standards can vary significantly between companies.

Some private banks have closed over the years, leaving families without access to their stored cells or forcing transfers to other facilities. A few banks have had quality issues or failed to maintain proper storage conditions. Because you are trusting a for-profit company to keep your child's cells viable for decades, the company's financial stability and track record matter.

Public banks, by contrast, are subject to stricter FDA oversight and are typically run by hospitals or non-profit organizations with longer institutional histories. If you do choose private banking, research the company's history, accreditation status, and whether they have ever had regulatory actions or customer complaints.

When private cord banking might make sense

Private cord banking is most defensible in specific situations. If your family has a diagnosed blood disorder (like sickle cell disease or thalassemia) and your newborn is a potential match for a sibling, private banking can preserve cells that might treat that sibling. Even then, directed public donation programs often offer the same service at lower or no cost.

If you have significant wealth and view cord banking as insurance against a low-probability but high-impact event, the cost may feel acceptable. But this is a personal financial decision, not a medical one — the odds remain the same regardless of your income. You are still paying thousands for a 1 in 200 to 1 in 400 chance of use.

For families without a family history of blood disorders, the math is harder to justify. The combination of low odds, uncertain long-term viability, and the free alternative of public banking makes private banking a poor financial bet for most people.

Frequently Asked Questions

Can I use my child's cord blood to treat a genetic disease they inherited?

No. If your child inherited a genetic mutation, their own cord blood carries the same mutation and cannot treat the disease. Cord blood transplants work for acquired disorders like leukemia, not inherited genetic conditions. If genetic disease runs in your family, public banking or a sibling's directed donation would be more useful than banking your child's own cells.

What happens to my child's cord blood if the private bank goes out of business?

If a private bank closes, your options depend on the company's closure plan. Some banks arrange transfers to other facilities; others may not. You could lose access to your stored cells. Public banks, run by hospitals or non-profits, have more stable long-term operations and are less likely to close unexpectedly.

Is cord blood banking covered by insurance?

Private cord banking is rarely covered by insurance because it is considered elective and preventive, not medically necessary. Public cord donation is free. If your child later needs a cord blood transplant, insurance typically covers the transplant procedure itself, regardless of whether the cells came from a private bank, public bank, or family donor.

How long can cord blood be stored?

Cord blood stored in liquid nitrogen can theoretically last indefinitely, but viability degrades over time. No private bank has data on cells stored for 50+ years because commercial cord banking only began in the 1990s. Cells thawed after 20 or 30 years may not function as well as fresher cells, and thawing itself can damage cells.

Should I donate to a public cord bank instead of paying for private banking?

Public cord banking offers the same medical benefit as private banking — your child can receive cord blood transplants if needed — at no cost to you. The trade-off is that you give up exclusive access to your child's own cells. For most families, this is a reasonable trade given the low odds of ever using stored cord blood and the significant cost of private banking.